Hyperkeratosis in athymic nude mice caused by a coryneform bacterium: microbiology, transmission, clinical signs, and pathology.
The purpose of this study was to characterize a spontaneous disease condition causing hyperkeratosis in nude mice and to explore the etiologic role of a particular species of coryneform bacteria in this disease, colloquially known as "scaly skin disease." The study was divided into two parts. In the first phase, a series of inoculation experiments was conducted with a field isolate of the coryneform species used to study the clinical and histopathologic development of the disease syndrome. Athymic nude mice (4 to 5 weeks old) were inoculated on the skin of the back with a suspension of a pure culture of the coryneform bacterium that had been isolated from a field case. The culture was applied with a sterile cotton swab in concentrations varying from 6.1 x 10(4)/ml to 5.0 x 10(7)/ml. All inoculated mice became persistently infected throughout the 33 days of the experiment. Clinically evident hyperkeratosis in inoculated animals developed more frequently in mice housed in a microisolator cage than in a semi-rigid isolator and more frequently in mice inoculated with higher numbers of organisms. In all animals in which hyperkeratosis developed, it was first noted on day 7 after inoculation. The second series of experiments was designed to determine the success of various housing methods in excluding the infection, mechanisms of transmission, susceptibility of other stocks and strains of mice to the organism, and whether the other strains might serve as a source of the organism. Results of the study in various strains indicated that both immunocompetent and immunodeficient mice, whether glabrous or hirsute, could be infected with the organism, but only glabrous animals developed hyperkeratosis.(ABSTRACT TRUNCATED AT 250 WORDS)
Clifford
C B
CB
Charles River Laboratories, Inc., Wilmington, Massachusetts, USA.
Walton
B J
BJ
Reed
T H
TH
Coyle
M B
MB
White
W J
WJ
Amyx
H L
HL
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003352:Corynebacterium / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D003354:Corynebacterium Infections / Q000382:microbiology / Q000473:pathology / Q000635:transmission / Q000662:veterinary*; D004817:Epidermis / Q000737:chemistry / Q000382:microbiology / Q000473:pathology; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D007633:Keratins / Q000032:analysis; D007642:Keratosis / Q000382:microbiology / Q000473:pathology / Q000662:veterinary*; D007769:Lactams; D018942:Macrolides; D008297:Male; D051379:Mice; D008819:Mice, Nude / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D012376:Rodent Diseases / Q000382:microbiology / Q000473:pathology / Q000635:transmission; D017192:Skin Diseases, Bacterial / Q000382:microbiology / Q000473:pathology / Q000635:transmission / Q000662:veterinary*
D000900:Anti-Bacterial Agents; D005227:Fatty Acids; D007769:Lactams; D018942:Macrolides; D007633:Keratins